Ufp Technologies (UFPT) Change in Receivables (2010 - 2026)
Ufp Technologies (UFPT) posted Change in Receivables of $15.7 million for Q1 2026, up 810.35% on a QoQ basis from -$2.2 million in Q4 2025, and up 76.47% year-over-year from $8.9 million in Q1 2025.
Ufp Technologies (UFPT) Change in Receivables (2010 - 2026) Analysis & Trends
Ufp Technologies' Change in Receivables history runs 17 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- Quarterly Change in Receivables rose 76.47% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 86.38% YoY) and the FY2025 annual result came in at -$5.3 million, down 338.54% from the prior year.
- Change in Receivables was $15.7 million for Q1 2026 at Ufp Technologies, up from -$2.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $15.7 million in Q1 2026 and bottomed at -$10.2 million in Q2 2025.
- A 5-year average of $2.1 million and a median of $3.3 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables surged 888.04% — and 2025, when it slumped 816.04%.
- Ufp Technologies' Change in Receivables stood at -$3.0 million in 2022, then surged by 211.96% to $3.3 million in 2023, then sank by 223.31% to -$4.1 million in 2024, then surged by 46.18% to -$2.2 million in 2025, then jumped by 810.35% to $15.7 million in 2026.
- Business Quant data shows UFPT's Change in Receivables at $15.7 million in Q1 2026, -$2.2 million in Q4 2025, and -$1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 15.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.71 Mn |
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | -2.21 Mn |
| Dec 31, 2025 | -2.21 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -10.17 Mn |
| Jun 30, 2025 | -10.17 Mn |
| Mar 31, 2025 | 8.90 Mn |
| Mar 31, 2025 | 8.90 Mn |
| Dec 31, 2024 | -4.11 Mn |
| Dec 31, 2024 | -4.11 Mn |
| Sep 30, 2024 | 7.12 Mn |
| Sep 30, 2024 | 7.12 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -3.12 Mn |
| Mar 31, 2024 | -3.12 Mn |
| Dec 31, 2023 | 3.33 Mn |
| Dec 31, 2023 | 3.33 Mn |